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Medullary thyroid carcinomaCalcitonin is a 32-residue polypeptide hormone, which takes part in calciummetabolism in bones. It
may form amyloid ﬁbrils. Amyloid ﬁbrils are related with serious diseases known as amyloidoses.
The amyloid form of calcitonin takes part in medullary thyroid carcinoma. A novel hexapeptide
(6TCMLGT11) of human calcitonin was predicted as a possible ‘aggregation-prone’ peptide, which
may play a role in amyloid formation. We investigated experimentally the ability of an analog of this
hexapeptide (cysteine replaced by alanine, TAMLGT) to form amyloid ﬁbrils utilizing TEM, X-ray ﬁber
diffraction, ATR FT-IR spectroscopy, and polarized light microscopy. This peptide self-assembles into
amyloid-like ﬁbrils and ﬁbrillogenesis is mediated via nuclei of liquid crystalline nature, known as
spherulites.
Structured summary of protein interactions:
TAMLGT peptide and TAMLGT peptidebind by x-ray ﬁber diffraction (View interaction)
TAMLGT peptide and TAMLGT peptidebind by infrared spectroscopy (View interaction)
TAMLGT peptide and TAMLGT peptidebind by electron microscopy (View interaction)
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A great number of proteins and peptides with different func-
tions and various structures are grouped together because of their
ability to form ordered ﬁbrillar aggregates, known as amyloid ﬁ-
brils. These ﬁbrils share distinct, common features: they bind Con-
go Red and display a characteristic yellow-green birefringence
under polarized light [1], they are seen, utilizing electron micros-
copy, as uniform, straight or slightly curved, unbranched and of
indeﬁnite length ﬁbrils, approximately 100 Å in diameter [2],
and, ﬁnally they produce cross-b X-ray ﬁber diffraction patterns
[3–5]. Amyloid ﬁbrils are related to diseases, such as Alzheimer’s
disease, atherosclerosis, cerebral amyloid angiopathy (Icelandic
type), type II diabetes, medullary thyroid carcinoma, which are,
collectively, called amyloidoses [6]. However, there are cases
where certain proteins or peptides with an amyloid-forming po-
tency play important functional roles in some organisms, including
insects [4], bacteria [7] and even humans [8].Calcitonin, a 32-amino acid polypeptide hormone [9] (Fig. 1), is
produced in mammals by the C-cells of the thyroid gland and in
lower vertebrates by the ultimobranchial body [10]. This hormone
(hereinafter called also hCT from human CalciTonin) is involved in
calcium-phosphorus metabolism [10]. Therefore, it is used as a
drug to treat various bone disorders like postmenopausal osterop-
osis [11], Paget’s disease [12] and also for short-term management
of severe symptomatic hypercalcaemia [13]. It has been found that
deposition of full-length calcitonin amyloid ﬁbrils is associated
with medullary thyroid carcinoma [14,15]. More speciﬁcally it
has been proved that full-length calcitonin hormone and not an
alternatively processed prohormone of calcitonin, forms amyloid
in medullary thyroid carcinoma [16]. It has also been found that
human calcitonin (hCT) may aggregate in vitro under speciﬁc incu-
bation conditions. Many studies have been done about the mecha-
nisms and kinetics of calcitonin ﬁbrillation [17,18].
It has been shown that ﬁve residues corresponding to positions
15–19 of hCT (DFNKF) play an active role in oligomerisation and ﬁ-
bril formation by hCT in vitro [19], and Lys-18 and Phe-19 have
been identiﬁed as key residues in both the bioactivity and self-
assembly of hCT [20]. Attempts were also made to convert the
highly amyloidogenic hCT into a powerful ﬁbril inhibitor by
three-dimensional structure homology with a non-amyloidogenic
Fig. 1. A schematic representation of the aminoacid sequence of mature human
calcitonin (hCT), which consists of 32 amino acid residues, is shown. There is a
disulﬁde bridge between Cys1 and Cys7 in mature calcitonin, essential for its
biological action, which is depicted by straight lines connecting the two residues,
above the sequence. A predicted ‘amyloidogenic determinant’/’aggregation-prone’
peptide (6TCMLGT11) by our algorithm AMYLPRED [23] is marked by ‘‘’’ (asterisks)
below the sequence. An analog of this peptide (6TAMLGT11), by replacing cysteine
(C) with alanine (A) (double arrow), was synthesized and studied in this work. This
peptide was also predicted to be ‘amyloidogenic determinant’/’aggregation-prone’
by AMYLPRED [23].
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bioactive calcitonin [22].
AMYLPRED is a consensus prediction algorithm for amyloid ﬁ-
bril favoring regions, the so-called amyloidogenic determinants/
‘aggregation-prone’ stretches, which was produced in our lab and
is freely available for academic users at http://biophys-
ics.biol.uoa.gr/AMYLPRED [23]. Testing the hCT sequence by AMYL-
PRED, the hexapeptide TCMLGT (residues 6–11 of the protein), was
predicted as a possible amyloidogenic determinant/‘aggregation-
prone’ sequence. We synthesized an analog of this peptide by
replacing cysteine with alanine in order to prevent the formation
of intermolecular disulﬁde bonds between cysteines, at approxi-
mately the neutral pH we wanted to perform the experiments.
We should note that, the ‘mutant’ peptide TAMLGT was predicted
by AMYLPRED as an ‘aggregation-prone’ peptide as well, in the
‘mutated’ calcitonin sequence.
In this work, the hexapeptide TAMLGT was tested experimen-
tally for fulﬁlling the criteria stated above, to see whether it is
capable of forming amyloid ﬁbrils or not. It will be shown below
that the tests were positive and that this hexapeptide self-assem-
bles to form amyloid ﬁbrils, via nuclei of liquid crystalline nature,
known as spherulites [24]. The fact that nuclei (spherulites) with a
liquid crystalline texture act as pre-ﬁbrillar intermediates in amy-
loid ﬁbril formation, has been observed in several other peptide or
protein systems forming amyloid ﬁbrils [24].
2. Materials and methods
2.1. Peptide synthesis
The TAMLGT peptide was synthesized by GeneCust Europe, Lux-
embourg (purity >98%, free N- and C-terminals).
2.2. Formation of amyloid-like ﬁbrils
The synthesized TAMLGT peptide was dissolved in doubly dis-
tilled water (pH 5.5), at a concentration of 15 mg ml1. Mature
amyloid-like ﬁbrils were formed after 1–2 weeks incubation at
ambient (room) temperatures, forming a ﬁbril-containing gel.
The ﬁbrils were judged to be mature, observing preparations both
for shorter and longer periods than 1–2 weeks. Oriented ﬁbers,
suitable for X-ray diffraction, were obtained from solutions of the
peptide, containing mature amyloid-like ﬁbrils as described below.2.3. X-ray diffraction
A droplet (10 ll) of mature ﬁbril suspension was placed
between two siliconized glass rods, spaced 1.5 mm apart and
mounted horizontally on a glass substrate, as collinearly aspossible. The droplet was allowed to dry slowly at ambient tem-
perature and humidity for 1 h to form an oriented ﬁber suitable
for X-ray diffraction. X-ray patterns were obtained immediately
from these ﬁbers since it was found that ﬁbers were drying and de-
stroyed, after 2 h under these conditions. X-ray diffraction pat-
terns were recorded on a Mar Research 345 mm image plate,
utilizing Cu Ka radiation (k = 1.5418 Å), obtained from a Rigaku
MicroMax-007 HF, microfocus rotating anode generator (with Os-
mic Rigaku VariMax™ HF optics), operating at 40 kV, 20 mA. The
specimen-to-ﬁlm distance was set at 150 mm and the exposure
time was 30 min. No additional low angle reﬂections were ob-
served at longer specimen-to-ﬁlm distances, up to 300 mm. The
X-ray patterns, initially viewed using the program MarView
(MAR Research, Hamburg, Germany), were displayed and mea-
sured with the aid of the program IPDISP of the CCP4 package [25].
2.4. Negative staining
For negative staining, the TAMLGT peptide ﬁbril suspensions
were applied to glow-discharged 400 mesh carbon coated copper
grids for 60 s. The grids were (occasionally) ﬂash-washed with
150 ll of distilled water and stained with a drop of 1% (w/v)
aqueous uranyl acetate for 45 s. Excess stain was removed by blot-
ting with a ﬁlter paper and the grids were air-dried. Pictures were
acquired in a Philips CM120 BioTWIN electron microscope (FEI,
Eindoven, The Netherlands) operating at 100 kV. Digital acquisi-
tions were made with a bottom-mounted Keen View 1K CCD cam-
era (Soft Imaging System, Muenster, Germany).
2.5. Congo Red staining and polarized light microscopy
TAMLGT ﬁbril suspensions were applied to glass slides and
stained with a 10 mM Congo Red (Sigma) solution in phosphate-
buffered saline (pH 7.4) for approximately 2 h. They were then
washed several times with 90% ethanol and left to dry. The samples
were observed respectively, both under bright ﬁeld illumination
and between crossed polars using a Leica MZ75 polarizing stereo-
microscope equipped with a JVC GC-X3E camera.
2.6. Attenuated total reﬂectance Fourier-transform infrared (ATR FT-
IR) spectroscopy and post-run computations of the spectra
Ten microliter drops of the TAMLGT peptide suspension (Sec-
tion 2.2) were cast on ﬂat stainless-steel plates, coated with an ul-
tra thin hydrophobic layer (SpectRIM, Tienta Sciences, Inc.
Indianapolis, USA) and left to air-dry slowly at ambient conditions
to form thin ﬁlms. IR spectra were obtained from these ﬁlms, at a
resolution of 4 cm1, utilizing an IR microscope (IRScope II, Bruker
Optik GmbH, Ettlingen, Germany), equipped with a Ge ATR objec-
tive lens (20) and attached to a FT-IR spectrometer (Equinox 55,
Bruker Optik GmbH, Ettlingen, Germany). Ten 32-scan spectra
were collected from each sample and averaged to improve the S/
N ratio. Internal reﬂection spectroscopy has several advantages
compared to the more common KBr dispersion technique [26].
The choice of ATR was dictated by the need to exclude any possible
spectroscopic and chemical interactions between the sample and
the dispersing medium. Having a penetration depth of less than
1 lm (1000 cm1, Ge), ATR is free of saturation effects, which
may be present in the transmission spectra of thicker samples.
The spectra were corrected for the effect of wavelength on the pen-
etration depth (p.d. / k). The corresponding effect of the (fre-
quency-dependent) refractive index (n) of the samples was not
taken into account due to the lack of relevant data.
The infrared ATR band maxima were determined from the min-
ima in the second derivative of the corresponding spectra. Deriva-
tives were computed analytically using routines of the Bruker
Fig. 3. X-ray diffraction pattern from an oriented ﬁber (F) of TAMLGT peptide
amyloid-like ﬁbrils. The meridian, M (direction parallel to the ﬁber axis) is
horizontal and the equator, E, is vertical, in this display. The X-ray diffraction
pattern is not a typical ‘‘cross-b’’ pattern since it shows rings instead of oriented
relections at the meridian and the equator. This, indicates a powder-like pattern of a
polycrystalline material. Nevertheles, it can easily be explained by looking at the
EM photographs of Fig. 2, assuming that the ribbons of the ﬁbrils, adopt all possible
orientations, despite our attempts to obtain an oriented ﬁber. A full explanation of
the diffraction pattern is given in the text, with a table of the d-spacings of the
diffraction rings and a proposed unit cell for the polycrystalline ﬁber (Table 1).
However, the typical to ‘‘cross-b’’, 4.57 Å and 10.9 Å reﬂections are seen. The 4.57 Å
reﬂection corresponds to the spacing of adjacent beta-strands (which should be
perpendicular to the ﬁber axis, and, consequently, the reﬂection perpendicular to
the meridian, in a typical ‘‘cross-b’’ structure), and the 10.9 Å spacing, which
corresponds to the face-to-face separation (packing distance) of the b-sheets.
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algorithm [27] over a ±8 cm1 range, around each data point.
Smoothing over narrower ranges resulted in a deterioration of
the signal-to-noise ratio and did not increase the number of min-
ima that could be determined with conﬁdence.
2.7. Crystalization experiments and polarized light microscopy
Quantities of freshly made peptide solutions in distilled water
(concentration 1 mg ml1, pH 5.5) were tested in crystallization
experiments, using the ‘‘hanging-drop’’ method, for the possible
formation of crystals. The precipitant was (NH4)2SO4 (concentra-
tion varied from 1.0 to 2.0 M). The samples were observed, both
under bright ﬁeld illumination and between crossed polars, respec-
tively, using a Leica MZ75 polarizing stereomicroscope equipped
with a JVC GC-X3E camera.
3. Results and discussion
The synthesized peptide (TAMLGT) self-assembles into amy-
loid-like ﬁbrils, after 1–2 week incubation in distilled water (see
Section 2) and forms a ﬁbril-containing gel. The ﬁbrils were judged
to be amyloid-like from their tinctorial and structural characteris-
tics. Transmission electron microscopy (negative staining) shows
that the ﬁbrils are straight, unbranched and of indeterminable
length (Fig. 2A and B). Each ﬁbril/protoﬁlament is about 40–50 Å
in diameter. Non-twisted ribbons/tapes were observed, as a result
of lateral interactions between multiple protoﬁlaments. Similar
ribbons/tapes have been observed in amyloid ﬁbrils from human
calcitonin [18]. The similarity is astonishing and it might imply
that this peptide plays a crucial role in human calcitonin ﬁbrilla-
tion. Future attempts for preventing hCT ﬁbrillation and producing
more effective drugs, should perhaps target this region of the mol-
ecule. While preparing peptide solutions, gels were quickly
formed, implying the existence of interacting amyloid ﬁbrils (data
not shown).
Fibers of TAMLGT ﬁbrils give an X-ray diffraction pattern
(Fig. 3), which closely resembles the typical ‘‘cross-b’’ patterns ta-
ken from oriented amyloid ﬁbers. However, the X-ray diffraction
pattern is not a typical ‘‘cross-b’’ pattern, since, instead of oriented
reﬂections at the meridian and the equator, it shows rings. This
indicates a powder-like pattern of a polycrystalline material. Nev-
ertheless, it can easily be explained by looking at the EM photo-Fig. 2. Electron micrographs (A & B) of mature TAMLGT peptide amyloid-like ﬁbrils, deri
ribbons, in many ways reminiscent of the ﬁbrils and ribbons formed by the entire calciton
indeed, intriguing. The samples were negatively stained with 1% uranyl acetate. Arrowsgraphs of Fig. 2, assuming that the ribbons/tapes of the ﬁbrils,
adopt all possible orientations in our attempts to obtain an ori-
ented ﬁber. A full explanation of the diffraction pattern is given
in the legend to Table 1, with a table of the d-spacings of the dif-
fraction rings and a proposed unit cell for the polycrystalline ﬁber.ved after 1–2 weeks of incubation. The ﬁbrils are seen to assemble laterally to form
in molecule [18]. The similarity in size of the ﬁbrils and appearance of the ribbons is,
show the width of a ﬁbril (40–50 Å). Bar 200 nm.
Table 1
Spacings (dobs) of the reﬂections observed in the X-ray diffraction pattern, taken from a
ﬁber of the 6TAMLGT11 peptide amyloid-like ﬁbrils (Fig. 3). Indexing (h, k, l, dobs, dcalc)
was done, utilizing DICVOL06 [38], a software for the automatic indexing of powder
diffraction patterns by the successive dichotomy method, based on an orthorhombic
unit cell, with unit cell parameters: a = 18.30 ± 0.02 Å, b = 18.53 ± 0.01 Å, c = 21.79 ±
0.01 Å, a = 90, b = 90, c = 90. This unit cell has a volume, Vol = 7388.96 ± 0.02 Å3 and
it is estimated to contain 8 molecules of TAMLGT, together with 8 associated water
molecules.
h k l dobs (Å) dcalc (Å)
0 0 2 10.90 10.89
2 1 0 8.20 8.20
0 0 3 7.25 7.26
1 2 2 6.58 6.58
2 1 3 5.45 5.44
1 2 3 5.45
0 0 4 5.45
3 2 1 4.96 4.96
4 0 0 4.57 4.57
4 2 0 4.10 4.10
4 0 3 3.87 3.87
0 5 0 3.70 3.70
0 5 2 3.51 3.51
0 5 3 3.30 3.30
4 2 6 2.72 2.72
0 0 8 2.72
2 7 3 2.40 2.40
5 4 5 2.40
4 5 5 2.40
3 2 8 2.40
1 0 9 2.40
0 1 9 2.40
Fig. 4. ATR FT-IR (900–1800 cm1) spectrum of TAMLGT peptide amyloid ﬁbrils,
cast on a ﬂat stainless-steel plate, coated with an ultra thin hydrophobic layer
(SpectRIM, Tienta Sciences, Inc. Indianapolis, USA) and left to air-dry slowly, at
ambient conditions, to form a hydrated, thin ﬁlm. A second derivative spectrum is
also included.
Table 2
Bands observed in an ATR FT-IR spectrum taken from a thin hydrated ﬁlm, formed
from the hCT hexapeptide-analog, TAMLGT, amyloid-like ﬁbril suspension, cast on a
ﬂat stainless-steel plate, coated with an ultra thin hydrophobic layer (SpectRIM,
Tienta Sciences, Inc. Indianapolis, USA), and their tentative assignments (see Section
2).
Band (cm1) Assignment
1140 TFA
1180 TFA
1203 TFA
1234 Amide III (b-sheet)
1531 Amide II (b-sheet)
1628 Amide I (b-sheet)
1674 TFA
1693 Amide I (antiparallel b-sheet)
Fig. 5. Photomicrographs of TAMLGT peptide ﬁbrils stained with Congo Red: (a)
bright ﬁeld illumination, (b) crossed polars. The yellow-green birefringence
characteristic for amyloid ﬁbrils is clearly seen. Bar 500 lm.
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reﬂections are seen. The structural repeat of 4.57 Å along the ﬁber
axis corresponds to the spacing of adjacent beta-strands (which
should be perpendicular to the ﬁber axis, in a typical ‘‘cross-b’’
structure) and the 10.9 Å spacing, which corresponds to theface-to-face separation (packing distance) of the b-sheets, parallel
to the ﬁber axis in typical cross-b patterns.
The ATR FT-IR spectrum of the TAMLGT peptide ﬁbrils, cast as a
thin-hydrated ﬁlm, is shown in Fig. 4. The spectrum shows a prom-
inent band at 1628 cm1 in the amide I region and the amide III
band at 1234 cm1, which are both deﬁnitely due to b-sheet con-
formation [28–32]. The amide I, high wavenumber component at
1693 cm1 is a strong indication that the b-sheets are antiparallel
[29–32]. In proteins containing antiparallel b-sheets, a high fre-
quency b-sheet component that arises from transition dipole cou-
pling is usually found 50–70 cm1 higher than the main b-sheet
component [31]. Other ATR FT-IR bands and their tentative assign-
ments are shown in Table 2. Thus, the results from ATR FT-IR spec-
troscopy strongly support the evidence from X-ray diffraction.
Also, the ﬁbrils formed from the TAMLGT peptide, bind the dye
Congo Red showing the characteristic green-yellow/green birefrin-
gence when viewed under crossed polars in a polarizing micro-
scope (Fig. 5).
Immediately after dissolving the peptide TAMLGT in distilled
water or during our attempts to crystallize it (see Section 2), hav-
ing seen from the X-ray diffraction experiments that it has a poly-
crystalline texture, it was found that the peptide spontaneously
assembles into supramolecular spherical structures, after 1–2 h
incubation, under a great variety of conditions. These structures,
when viewed in a polarizing microscope under crossed polars,
are seen to have a liquid crystalline texture. They are spherulites
Fig. 6. Photomicrographs of TAMLGT peptide spherulites viewed in a polarizing microscope under crossed polars (A and B). These supramolecular spherical structures, with a
liquid crystalline texture, are formed spontaneously after 2–4 h incubation, under a great variety of conditions. Characteristic ‘‘Maltese extinction crosses’’ are clearly seen
(arrows). The spherulites appear to have diameters ranging from 10 to 200 lm. (A) Bar 500 lm, (B) bar 110 lm.
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ranging from 10 to 200 lm (Fig. 6A and B).
These liquid crystalline structures can be found in many other
amyloid-ﬁbril forming proteins [24,33–36]. Thus, amyloid ﬁbrillo-
genesis proceeds via spherulites for proteins and peptides involved
in functional amyloids like silkmoth chorion and spider silk and
pathological amyloids (Ab42 involved in Alzheimer’s disease)
[24,35 and references therein] and for insulin, albumin, b-lacto-
globulin and pro-IAPP [34–36 and references therein]. Spherulites
have also been found in vivo, in the hippocampal tissue, in Alzhei-
mer’s disease [33]. Therefore, it is tempting to assume that amyloid
ﬁbrillogenesis proceeds, in several cases via intermediates of liquid
crystalline nature, a fact initially recognized by our team ﬁndings
[24] and that, in several cases, the pre-ﬁbrillar amyloid intermedi-
ates, important for the pathogenicity in amyloidoses are, indeed,
these spherulitic structures.
At this point, it is perhaps interesting to draw attention to the
relation of spherulites (as ordered domains of hydrogels) to the
general theory of formation of hydrogels, which may be formed
by different types of synthetic polymers [37 and references there-
in]. A full understanding of the process that leads from spherulites
to amyloid ﬁbrils, is likely to lead not just to advances in our
understanding of amyloid diseases and the formation of functional
amyloids, but also to a fundamental understanding of assembly
characteristics, for possible exploitation in the generation of novel
biomaterials and in nanotechnology.
Our future attempts (in progress) will be focused to produce
more soluble/effective variants of hCT, designing non-ﬁbrillating
mutants of calcitonin, by performing mutations in this part of
hCT, involving this peptide.
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